Abiopharma

Elanco to Participate in the Upcoming Investor Conferences

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach

4DMT to Participate in 8th Annual Evercore Healthcare Conference

Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference

FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers

Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results

Oncotelic Achieves Breakthrough $1.7 Billion Pipeline Valuation Through GMP Bio Joint Venture

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments